California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2024, West had total debt outstanding of $203 million. West has ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Embecta's compelling ~44% free cash flow yield offers a strong risk-reward despite headwinds from new insulin technologies ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

TIRUCHY: The early detection of Type 1 diabetes in children is improving due to enhanced school health screenings and ...

The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.

It said about a quarter of medicines dispensed by hospital pharmacies were for medication patients are already taking before ...

The approval is for both a 3 milliliter or mL single-patient-use prefilled pen and a 10 mL multiple-dose vial. As a rapid-acting human insulin, Merilog helps to lower mealtime blood sugar spikes ...